An artificial intelligence (AI) tool for assisting in real-time diagnosis during surgery has been developed, according to a recent study. In order to improve the precision of quick diagnostics, it can improve image quality.
In order to better diagnosis and produce treatment guidelines for rare diseases, research at the Brigham and Women’s Hospital in Boston, Massachusetts, has created a deep learning system that can teach itself to find comparable patterns in massive pathology picture archives. The research was released in the journal Nature Biomedical Engineering.
Faisal Mahmood, PhD, of the Division of Computational Pathology at the Brigham and Women’s Hospital in the US, who is the study’s corresponding author, stated that “We are utilising the power of artificial intelligence to address an age-old problem at the junction of surgery and pathology.”
The method is known as Self-Supervised Image Search for Histology (SISH), and the researchers created a deep-learning model that can be used to translate between frozen sections and the more popular formalin-fixed and paraffin-embedded (FFPE) tissue samples. FFPE tissue samples are a labor-intensive and time-consuming method for preserving tissue that results in high-quality images. The potential for this technique to “enhance pathology training, illness subtyping, tumour diagnosis, and rare morphology identification” was also underlined.
Deep learning’s most fundamental goal is to use algorithms to replicate the intricate neural networks in our own brains. Similar to what we do every day, these computers were taught to learn things about data sets by seeing patterns and trends.
“Our research demonstrates how AI has the potential to assist pathologists in making a crucial, time-sensitive diagnosis. Additionally, it might be used for any kind of cancer surgery. It offers numerous opportunities to enhance patient care and diagnostics “Added Mahmood.
Numerous research publications from the past have concentrated on the application of AI to medical diagnosis. For instance, computer scientists and artificial intelligence researchers at MIT’s CSAIL created an AI diagnostic system in January that aids in making a choice or diagnosis based on its digital results.
According to CSAIL researchers, “Machine learning systems are currently being used in settings to [supplement] human decision makers.” The study, according to the researchers, focuses on areas like content moderation with social media sites like Facebook or YouTube for better decision making in addition to clinical applications of AI.
The global market for AI medical diagnostics is anticipated to rise from $748 million in 2021 to $4.0 billion in 2026, at a compound annual growth rate (CAGR) of 39.8% for the projection period of 2021–2026, according to Boston-based research firm BCC Research.
